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Many patients who develop incapacitating illness have not ex-
pressed clear treatment preferences. Therefore, surrogate decision
makers are asked to make judgments about what treatment
pathway is most consistent with the patient’s values. Surrogates
often struggle with such decisions. The difficulty arises because
answering the seemingly straightforward question, “What do you
think the patient would choose?” is emotionally, cognitively, and
morally complex. There is little guidance for clinicians to assist
families in constructing an authentic picture of the patient’s values
and applying them to medical decisions, in part because current
models ofmedical decisionmaking treat the surrogate as the expert
on the patient’s values and the physician as the expert on technical
medical considerations. However, many surrogates need assistance
in identifying and working through the sometimes conflicting
values relevant tomedical decisions near the end of life.We present
a framework for clinicians to help surrogates overcome the emo-
tional, cognitive, and moral barriers to high-quality surrogate deci-
sion making for incapacitated patients.
Keywords: surrogate decision making; patient-centered care; ethics;
critical care; shared decision making
Many patients who develop incapacitating illnesses have not left
oral or written directives about their treatment preferences (1,
2). Even when a patient has completed an advance directive, it
often does not provide clear guidance regarding the actual med-
ical situation. Therefore, others, generally family members with
a close relationship to the patient, are asked to make judgments
about which treatments are most consistent with the patient’s
values (3). However, surrogate decision makers often struggle
in this role (4–6) and experience substantial psychological bur-
dens when making decisions for their loved ones (7). Empirical
research suggests that surrogates make different decisions than
patients would make for themselves in roughly one-third of
cases (8, 9).
The difficulty arises because clinicians often treat the question
“What do you think the patient would choose?” as relatively
straightforward and fail to appreciate its emotional, cognitive,
and moral complexity. However, there is little guidance for
clinicians to assist families in constructing an authentic picture
of the incapacitated patient’s values. This may be due in part to
conventional views of medical decision making, which draw
distinct boundaries between the expertise of physicians (e.g.,
technical medical judgments) and surrogates (e.g., the patient’s
values) (10). Research suggests this division also exists in clin-
ical practice: in audiotaped clinician–surrogate conversations,
physicians frequently neither elicit patients’ values nor offer
treatment recommendations (11, 12).
This conceptualization of the physician’s role is flawed. Al-
though surrogates generally have significantly more knowledge
of patients’ values and preferences than do clinicians (13), this
knowledge is only part of what is required to fulfill the role of
surrogate decision maker. Just as patients often need assistance
in clarifying their values about difficult medical decisions (14),
so too might surrogates need assistance to think through the
patient’s values and to apply them to complex medical deci-
sions. This is especially true for the high-stakes, emotionally
charged decisions that surrogates are asked to consider for
patients with advanced critical illness.
We explored diverse areas of scholarship, including bioethics,
decision psychology, and medical communication science, to
more comprehensively address these challenges. Using this liter-
ature and clinical experience, we developed the Facilitated Val-
ues History to help clinicians assist surrogates in constructing
a comprehensive view of a patient’s health-related values and
choosing a treatment pathway that is consistent with them.
AUTONOMOUS DECISIONS OR
AUTHENTIC DECISIONS?
A common misperception among clinicians is that respect for
autonomy is the ethical principle that drives most decisions
for incapacitated patients (15). However, a decision cannot be
autonomous unless the patient actually made a specific choice in
advance about the medical situation at hand. When the inca-
pacitated patient has not previously communicated a relevant,
applicable choice, as is generally the case in ICUs, clinicians
cannot be guided primarily by respect for autonomy. Instead,
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when clinicians ask families “what do you think the patient
would choose?” their goal is generally to make an authentic
decision for the patient—a decision informed by knowledge of
the patient’s values and motivated by an intention to deliver
care that respects the patient as a person. This distinction is
important because it highlights the need for clinicians to gain
a robust understanding of the patient’s values before making
treatment recommendations (16).
VALUES IN TENSION NEAR THE END OF LIFE
Although it is unquestionably true thatmost people have a “pow-
erful desire to not be dead” (17), a growing body of research
demonstrates the limits of this desire (17–23). Table 1 summa-
rizes empirical research on values particularly relevant to end-
of-life decisions and “states worse than death” (17–23). The
relevant values are not the complete set of a patient’s values
but what the patient values about being alive and what she is
willing to go through for a particular chance to survive with an
acceptable quality of life.
Advanced illness often raises tradeoffs between quantity and
quality of life (24). For example, an intellectual may prefer
being allowed to die rather than endure a life of severe cogni-
tive impairment. Someone who views interpersonal interactions
as the source of life’s value may opt against life prolongation
when no longer able to maintain relationships. Individuals who
highly value bodily integrity may believe that dependence on
invasive medical technologies is undignified. Two central goals
of communication with surrogates should be to understand the
patient’s unique perspective on what gives life meaning and to
recommend a treatment plan consistent with those values.
THE FACILITATED VALUES HISTORY
The following seven behaviors make up the Facilitated Values
History. Each is explained in terms of barriers to good decisions
and actions the clinician can use to target them. Table 2 contains
sample language for each action.
Attend to Surrogates’ Emotions
Barriers. Research in decision psychology suggests that strong
emotions can impair information processing and reasoning (6).
Research participants experiencing strong emotions demonstrate
different areas of brain activation on functional magnetic reso-
nance imaging and different decision making—corresponding to
a “fight or flight” mentality—compared with participants not
experiencing strong emotions (25, 26). These changes may influ-
ence surrogates’ ability to make decisions that involve difficult
tradeoffs between quantity and quality of life.
Additionally, decisions about life support require surrogates
to consider that they may need to “let go” of their loved one.
If emotions are inadequately addressed, some surrogates may
make treatment choices contrary to the patient’s values to avoid
the negative emotions caused by the death of a loved one (27, 28).
Practical actions. Clinicians should view attending to sur-
rogates’ strong emotions as an equally important obligation to
sharing medical information (29). There is an extensive litera-
ture on attending to emotions in clinical encounters (29). Three
simple actions may be beneficial and readily incorporated into
clinicians’ practice: talking openly about emotions, expressing
empathy, and enlisting experts from the interdisciplinary health-
care team to provide ongoing emotional support to surrogates
(Table 2) (29–31). One way to operationalize addressing emo-
tions is the NURSE mnemonic (32). As little as 40 s of emotional
support by clinicians is associated with decreased anxiety among
patients making difficult medical decisions (33). The most over-
whelmed surrogates may require temporary delays in decision
making to first focus on helping them cope with the circum-
stances at hand.
Help Surrogates Understand Their Contribution
to Decision Making
Barriers. Surrogates maymisconstrue their role in decisionmak-
ing in important ways. Theymay believe that treatment decisions
hinge on purely medical judgments rather than on value-laden
ones and therefore underestimate the importance of their input
regarding the patient’s values (34). On the other hand, some
may mistakenly believe that they have sole authority to deter-
mine the treatment plan. Additionally, some surrogates make
errors due to projection bias, consciously or unconsciously mak-
ing decisions based on their own values or desires for the patient
rather than the patient’s values (34, 35).
Practical actions. Physicians should clarify that decisions near
the end of life are value-laden and emphasize that the family’s
input is essential (24). To minimize projection bias, it may be
helpful to explain that the patient’s values should predomi-
nantly guide decisions. This point can be experientially con-
veyed by first asking what the surrogate might choose for
herself in the patient’s condition, then asking what the patient
might choose. This approach serves to distinguish the patient’s
values from the surrogate’s while allowing the surrogate to openly
TABLE 1. VALUES COMMONLY RELEVANT TO END-OF-LIFE DECISIONS
Domain of Health Values Explanation of Value
Longevity Living as long as possible
Living until a specific goal is reached (e.g., birth in the family, return of a loved one from abroad)
Maintenance of bodily integrity Avoiding having the body cut, attached to machines, or otherwise acted on by outside agents
Avoiding prolonged dependence on life-sustaining treatments
Maintenance of physical function Maintaining physical independence
Maintaining specific physical abilities (e.g., driving, athletics, playing a musical instrument)
Maintenance of cognitive function Being able to think clearly
Autonomy and independence Being able to make one’s own decisions
Being able to live at home
Not living in a nursing home
Avoiding burdening one’s friends and family financially, physically, or emotionally with one’s care
Being willing to accept help when limitations occur
Social and emotional engagement Participating in relationships
Contributing to one’s social group
Avoidance of burdensome physical symptoms Avoiding pain, dyspnea, nausea, or other symptoms
Adherence to religious or spiritual beliefs Ensuring that treatment is consistent with religious precepts
Developed based primarily on work by Fried et al. (17), Patrick et al. (20), Pearlman et al. (21), and Karel et al. (22).
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discuss her hopes for the patient. Clinicians can also explain the
value of making decisions that honor a patient’s individuality (15,
36). Such framing may counterbalance the emotional difficulty of
forgoing life-prolonging treatments with the moral consolation of
striving for authentic decisions for the patient.
Understand the Patient as a Person
Barriers. The common absence of an established relationship
between clinicians and patients in ICUs can be a serious barrier
to shared decision making (16, 34). Clinicians who do not know
the patient as a person are poorly positioned to deliberate with
surrogates about decisions that hinge on the patient’s unique
values (26). Furthermore, surrogates may not welcome physicians
into sensitive decisions unless they believe that they care for the
patient as a unique individual (35, 37).
Practical actions. Rather than beginning conversations by fo-
cusing on specific treatment decisions, we suggest first inquiring
about the patient as a person. The goal is to elicit a narrative
about the patient’s life experiences, relationships, and beliefs.
Narratives help people make sense of complex situations (15).
Just as physicians routinely elicit the history of the present ill-
ness to understand the patient’s clinical condition, inquiring
about the patient as a person may help clinicians situate the
TABLE 2. THE FACILITATED VALUES HISTORY
Behavior Specific Actions Examples
Attend to surrogates’ emotions NURSE mnemonic N-ame the emotion: “You seem upset.”
U-nderstand the emotion: “This is such a hard thing to go through.”
R-espect the family: “You are doing a wonderful job of representing your mother.”
S-upport the family: “How are you and your family doing?”
E-xplore the emotion: “Tell me more about why you feel that way.”
Enlist interdisciplinary
support
Help surrogates understand their
contribution to decision making
Explain that decisions
are value laden
“Different people feel very differently about what kind of
treatments they would accept if they became very sick. We hope
you can help us understand what your dad’s views are.”
Reduce projection biases “Our goal should be to honor your mother by trying to
understand what she would choose if she were sitting here.”
“Sometimes it is really hard to separate what you might want
for your father from what he might choose for himself, but it is
really important to try.”
Understand the patient as a person “Tell me what your dad liked to do before he came in the hospital.”
“As he was getting sicker, what did he worry about the most?”
“What was she like?”





Explore attitudes about physical/cognitive impairment, social functioning,
religious beliefs, prolonged use of life support
Explore advance directives
Point out values in tension/conflict
Explore which values would be most important if all could not be fulfilled simultaneously
Summarize the values relevant to
the decision
“We have covered a lot in this conversation. Can I tell you what I’ve heard?
It sounds like your brother valued being able to take care of himself. His
work as an editor was important to him. He would not want to live in a
nursing home under any circumstances, and wouldn’t want to be kept alive
by machines in the long term, but would accept life support temporarily
if there was a reasonable chance he could get back to living independently
and working as an editor. Have I missed anything?”
Bridge between values and treatments Demonstrate bridges For “hypothetical patients”: “If your mother felt that living as long as possible
regardless of quality of life was the most important thing, then it
would be most appropriate to keep her on the breathing machine, place
a feeding tube, and begin to explore options for a place where she can
remain on a ventilator long term. If she felt that the treatments she is
receiving would not have enough of a chance of restoring her to an
acceptable quality of life, then we should stop these invasive treatments
and begin to focus on maximizing her comfort and the other things that
would be important to her during this time.”
Based on the patient’s values: “Based on what you have told me about
your Mom, I recommend a trial of being on the ventilator to see if things
get better quickly. If they don’t, then we should focus on keeping her
comfortable and remove her from the ventilator.“
Give “permission” to follow the
patient’s wishes
Express empathy “These decisions are hard. You are doing a really good job advocating
for you mom.”
“I can see this is upsetting.”
Address moral concerns “Sometimes people are worried about whether it is okay to make these decisions.
Are you concerned about this?”
“One important way to respect your father as a person is to make decisions
that fit with his values.”
Share social norms “Some families are concerned that stopping life support isn’t allowed. In fact,
it’s common in intensive care units to stop treatments when it’s clear that they
aren’t going to achieve the patient’s goals.”
Provide patient-centered recommendations
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illness in the broader context of the patient’s life. It also may
help develop a trusting clinician–surrogate relationship, reveal
key values that can be explored subsequently, and allow fami-
lies to engage in the type of conversations that are an important
dimension of anticipatory grieving (38).
Explore Specific Values and Value Conflicts
Barriers. Surrogates face at least three challenges in constructing
an authentic vision of the patient’s values. First, they may strug-
gle to identify the variety of relevant values (24). For example,
surrogates may focus narrowly on the value of being alive and
fail to consider what the patient considers an acceptable quality
of life (39). Second, they may struggle to weigh conflicts be-
tween values. Although no studies of surrogate decision making
have addressed value conflicts, such conflicts plague patients
facing difficult medical decisions and can be ameliorated by
values clarification exercises (14, 40). Third, surrogates may
be unduly motivated by the “Rule of Rescue,” which is “the
moral response to the imminence of death [which] demands that
we rescue the doomed” (41).
Practical actions. Clinicians should ensure that the variety of
potentially relevant values is discussed. One way to begin this
conversation is to ask a general question about the patient’s
views on quality versus quantity of life, such as “Would your
father want to live as long as possible, regardless of his quality
of life, or would he prioritize a good quality of life, even if it
meant he would not live as long?” (23). We have developed
eight questions to elicit considerations important to many
patients near the end of life (Table 3) (21, 42, 43). The goal
of these questions is to gain insight into how different impair-
ments might affect the patient’s perceived quality of life.
Clinicians should anticipate that sometimes surrogates’ initial
responses to these questions may be driven more by their per-
sonal desire for the patient to survive rather than the patient’s
values (e.g., “Dad would never want to give up.”) (42). Clinicians
should recognize that these responses express emotions, address
them appropriately, and then gently explore whether there may
be more to be understood about the patient’s values: “You
clearly love your father very much.tell me more about him.”
Such conversations often reveal conflicting values. For exam-
ple, patients may value both extending life and maintaining func-
tion. Clinicians should articulate these value conflicts and ask
surrogates how the patient would have viewed them (17, 40).
For example, they might say, “If I understand you correctly, it
sounds like your father values both being alive and also being
able to live independently and interact with his friends and
family. If it was likely that he couldn’t communicate or would
be dependent on others for basic care such as dressing and
bathing himself, what do you think he would say about the sorts
of medical treatments he would want?” (17, 18, 20, 21).
The influence of the Rule of Rescue can be addressed in two
ways. First, rather than presenting potential treatment path-
ways as “do everything” versus “do nothing,” clinicians should
emphasize that all pathways involve active treatment: “We are
going to do everything we can to give your father the kind of
treatment he would want in this situation” (43). Second, clini-
cians can ask whether the patient might consider certain states
“worse than death”—so unacceptable that death would be bet-
ter than enduring them (Table 2) (21). Discussing states worse
than death may allow surrogates to make the psychological leap
to see that “doing everything” to extend life may not be con-
sistent with the patient’s authentic values (42, 43).
Summarize the Patient’s Values Relevant to the Decision
Barriers. Mutual understanding of patients’ values is a prerequi-
site to shared decision making. If deliberations are lengthy
or complex, clinicians and surrogates may understand them
differently. Moreover, some surrogates may be so focused on
details that they need assistance to gain a full perspective on the
patient’s values.
Practical actions. Physicians should restate the central values
they have heard during the conversation to ensure shared under-
standing. Summarizing allows surrogates to assess whether the
picture of the patient’s values is complete and accurate and to
modify it accordingly.
Bridge from the Patient’s Values to Specific
Treatment Pathways
Barriers. Some surrogates who have a clear understanding of
a patient’s values may still struggle to understand which treat-
ment pathway is most consistent with those values. Some may
need assistance to bridge the gap between the “lay world” of
patient values and the “medical world” of treatments (9, 19, 27).
Practical actions. It may be helpful for clinicians to make an
explicit “bridge” between treatment pathways and the values they
embody (11). Table 2 provides examples of both patient-centered
recommendations and recommendations for “hypothetical” pa-
tients with different values. We recommend that when clinicians
make treatment recommendations, they should not simply state
the recommendation but also “show their work” by explaining
how they moved from the patient’s particular values to a judgment
about the most appropriate treatment pathway. For example,
rather than stating, “I recommend that we focus on a comfort-
oriented treatment plan,” physicians should say, “Based on how
important it is to your father to avoid being kept alive on machines
TABLE 3. EIGHT QUESTIONS EXPLORING VALUES
Value Question
Longevity Was your loved one someone for whom it was important to live as long
as possible, regardless of his quality of life?
Maintenance of bodily integrity What would your loved one think about his quality of life if it turned out that
he would be permanently dependent on a mechanical ventilator?
Maintenance of physical function What would your loved one think about her quality of life if she were unable to
walk and had serious difficulty in doing daily activities like feeding herself or bathing?
Maintenance of cognitive function How would your loved one think about his quality of life if he were severely cognitively
disabled, in terms of having limited ability to think or communicate?
Autonomy and independence How would your loved one think about her quality of life if she were unable to make
her own decisions?
Social and emotional engagement How would your loved one think about his quality of life if he became unable to hold
conversations or interact meaningfully with you?
Avoidance of burdensome physical symptoms How would your loved one think about her quality of life if she had to endure ongoing
discomfort from pain, shortness of breath, thirst, or other symptoms?
Adherence to religious or spiritual beliefs Did your loved one have any religious beliefs that would guide her medical treatment?
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if he faced serious cognitive and physical impairments, I recom-
mend that we focus on a comfort-oriented treatment plan.”
Some families may desire substantial guidance from physi-
cians regarding decisionmaking. For these families, personalized
treatment recommendations may be especially important (6,
7, 27, 44). A small minority of surrogates may wish to cede
decisional authority to clinicians (44). The ethical and practical
aspects of these situations are beyond the scope of this article
but have been addressed by others (45).
Give “Permission” to Follow the Patient’s Values
Barriers. Even when forgoing life-prolonging treatments is
clearly most consistent with a patient’s values, surrogates some-
times struggle to authorize it because of the emotional difficulty
of facing the death of a loved one, moral or legal concerns about
causing death, or concerns that forgoing life support violates
prevailing social norms (46). Individuals with limited exposure
to modern medical technologies may be unaware that forgoing
life support is commonplace in the care of patients with ad-
vanced illness (17, 47).
Practical actions. As noted previously, attending to the emo-
tional difficulty of letting go of a loved one may help overcome
surrogates’ emotional barriers to enacting patient-centered de-
cisions. Empirical evidence indicates that clinicians often do not
express empathy during deliberations about whether to forgo life
support but that families are more satisfied when they do (30).
When legal or moral concerns arise, clinicians should clarify
that withholding and withdrawing life support is legal in the
United States and is allowed in virtually every religious tradition.
Hospital chaplains or clergy from the patient’s tradition may help
alleviate religious concerns. When surrogates perceive forgoing life
support as patient abandonment or betrayal of a vulnerable loved
one (7, 47), physicians can explain that deciding based on the
patient’s values is an important way to respect the patient as a per-
son and protect her from treatments contrary to her values (15).
If surrogates misperceive social norms regarding end-of-life
decision making, physicians should provide information about
them. For example, they can explain that many patients forgo
life-prolonging treatment near the end of life (47). Making a
treatment recommendation may reassure surrogates that a plan
of care is socially acceptable.
It is beyond the scope of this article to address situations in
which surrogates are ultimately unwilling or unable to authorize
the treatment plan most consistent with the patient’s values.
Proposed strategies for such situations include ongoing emo-
tional support and negotiation (48), physician-driven decision
making (44, 45), legal removal of the surrogate (49), and pro-
cedural dispute resolution (50).
LIMITATIONS OF THE FACILITATED VALUES HISTORY
The Facilitated Values History is intended for situations in which
the surrogate has knowledge of the patient as a person. Surrogates
who lack sufficient knowledge must rely on other standards to
guide decision making, such as the best interest standard (51).
There is a risk that some surrogates could experience psycho-
logical distress if they mistakenly believe that their responsibility
is to discover the unknowable “right answer” to the question of
what the patient would choose when the patient had not made
a choice in advance. Therefore, clinicians should be careful
to avoid language that implies this is the goal and instead em-
phasize that the goal is to select a treatment pathway that is
consistent with the patient’s health-related values and respectful
of the patient as a person.
The reality of modern intensive care is that there is often
more than one clinician managing the goals of care conversation
with the family. Empirical research is needed to understand how
best to integrate the Facilitated Values History into the complex
care teams that serve critically ill patients.
STRENGTHS OF THE FACILITATED VALUES HISTORY
This framework fills a void about how clinicians can assist surro-
gates in making authentic decisions for patients who have not ar-
ticulated specific treatment preferences. It conceptualizes decision
making not merely as a cognitive process but also as an emotional
andmoral one.Becausemost cultural groups value treating patients
as ends in themselves, rather than merely as means to an end, this
framework should be broadly acceptable in pluralistic societies. It
fits within social and legal frameworks for surrogate decision mak-
ing. It may benefit clinicians by countering the depersonalization of
care that has been associated with clinician burnout (52). Many
elements of the framework could be implemented by nurse or
social work members of the healthcare team, thus promoting in-
terdisciplinary collaboration for patients with advanced illness.
POTENTIAL CRITICISMS OF THE FACILITATED
VALUES HISTORY
Some may worry that physicians could misuse this approach to
paternalistically influence decisions that do not advance the
patient’s interests. Because the approach is explicitly grounded
in gaining a clear vision of the patient’s values, and surrogates
retain decisional authority, this possibility is diminished. The
Facilitated Values History requires trust that physicians will
strive to promote the patients’ interests; this is not different
from what is required of clinicians currently.
Others may be concerned that because this approach is not
“value-neutral,” it extends beyond the realm of physicians’ ex-
pertise. It is untenable to argue that physicians can maintain
neutrality in the decision-making process. Moreover, in this
approach, the patient’s interests and values are ultimately de-
fined by the family, not the physician. The physician’s role is to
elicit patient values in a comprehensive way and to reduce the
impact of cognitive, emotional, and moral factors that may
threaten patient-centered decisions.
Some may argue that this approach limits physicians’ ability
to make strong treatment recommendations based on their views
of what is in the patient’s best interest. However, the Facilitated
Values History makes no restrictions on the strength of physi-
cian’s treatment recommendations. Instead, it encourages genu-
ine involvement of the physician through attempts to understand
the values of the incapacitated patient and then make treatment
recommendations that respect the patient’s values.
TABLE 4. QUESTIONS EXPLORING VALUE CONFLICTS
d Is your husband someone who would want to live as long as possible regardless of quality of life, or was quality of life important?
d What would your brother say if his illness made it so that he would need other people to help him with basic physical care, but he would be able to think clearly and
interact with his family?
d What would your wife say if she were no longer able to make decisions for herself and look after herself, but she could be awake and recognize her family?
d People with advanced cancer who survive critical illness usually only live a short time longer—days, weeks, or months. What do you think your aunt would say about
whether it was worth it to go through invasive treatment to achieve that?
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Although expert clinicians may already use some individual
behaviors of the Facilitated Values History, this systematic
approach has not been formally articulated and goes beyond
the commonly taught role for clinicians in surrogate decision
making. Additionally, although written documents have been
proposed to help competent patients consider their values
(22, 23), the Facilitated Values History is unique in focusing
on surrogates rather than patients, attending to the emotional
and moral considerations of decision making, and being imple-
mented through conversation rather than a pen and paper ex-
ercise. As with other complex procedures, clinicians will likely
increase their skills in this domain through training and practice.
Finally, some argue that the problems addressed by this ap-
proach can be eliminated by increased completion of advance direc-
tives. Although advance directives are clearly important, modern
advance care planning efforts are evolving from a document-
driven, decision-focused event to a process that prepares surro-
gates to make in-the-moment judgments (53, 54). Therefore, it is
likely that the need for interventions like the Facilitated Values
History will increase rather than decrease over time.
CONCLUSIONS
The Facilitated Values History is a structured approach for
clinicians to assist surrogate decision makers in understanding
incapacitated patients’ values and applying them to treatment
decisions. Its seven behaviors address common emotional, psy-
chological, cognitive, and moral barriers to high-quality surro-
gate decision making. It provides practical guidance to achieve
the dual ethical goals of providing patient-centered care for
incapacitated patients and supporting families facing the daunt-
ing task of deciding for others.
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